Navigation Links
Report card praises Wisconsin economy, but comes with warning
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Report card praises Wisconsin economy but comes with warning

(Date:9/5/2008)...swire-FirstCall/ -- BioSpecifics,Technologies Corp...company,developing first in class collagenase base...agreement to significantly improve the deal terms ...onie,s disease by buying down its,future royalty o...ifics has modified its previously announced agreem...
(Date:9/5/2008)...ed to Expand Business Development Efforts, SALT L...c., a company,focused on the development of molecu...in the spine care market, announced today that Joe...the company,s new Vice President of,Strategic Init...al Biotech,s global efforts to,identify, evaluate,...
(Date:9/4/2008)...Newswire-FirstCall/ -- BioForm Medical,Inc. (Nasd...for the fourth,quarter and full fiscal year ended ...e quarter ended June 30, 2008 as compared to $15.4...ncrease of $1.3 million or 8.4%.,The net loss was ...as,compared to a net loss of $4.9 million for the ...
(Date:9/4/2008)... 4 /-, - Prevenar Vaccine ...ne-Preventable Cause of Death in Young Children Wo...e Republic of Ireland have,initiated national immu...hildren against pneumococcal disease by adding Pre...ine, Adsorbed), also called PCV7, to their,nationa...
Breaking Biology Technology:BioSpecifics Technologies Corp. Buys Down Royalties for Peyronie's Disease 2Axial Biotech appoints new Vice President of Strategic Initiatives 2BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 2BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 3BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 4BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 5BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 6BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 7BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 8BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 9Cyprus and Ireland Add Wyeth's 7-Valent Pneumococcal Conjugate Vaccine (PCV7) to Their National Immunisation Schedules 2Cyprus and Ireland Add Wyeth's 7-Valent Pneumococcal Conjugate Vaccine (PCV7) to Their National Immunisation Schedules 3
...Internet Corporation for Assigned Names and Number...rnet is completely useless. That golden key is a n...ster design of a sophisticated key management syst...es can offer access to billions of sites without a...ternet has no value. ,It,s this portion of the mag...
...or pundits everywhere to predict every possibility... and the more I looked at it, the more it became o...06. , ,I share this with a minor tremor of trepida...80s, when each year was declared with increasing ...t to say may seem a little like that. After all, t...
...006! I sit hear writing this article as I listen, ...ed "Cream Gold" (released in 2005 - not to be conf...hy Cream, you may ask? Well, the successful re-eme...concerts held in London and NewYork,s Madison Squa... baby-boomer. I caught a part of these concerts on...
...has finished its acquisition of health-care IT com...dding to GE,s suite of clinical, imaging and busin... Healthcare, said the combination would lead to ex...ic health records. , ,The business will be led by ...,s Information Technologies division. IDX Systems,...
Other Biology Technology:When will the Internet be divided among nations? 2When will the Internet be divided among nations? 3When will the Internet be divided among nations? 4When will the Internet be divided among nations? 5The year of working together (really!) 2The year of working together (really!) 3Biotech flourishes in 2005 while Big Pharma is on the decline 2Biotech flourishes in 2005 while Big Pharma is on the decline 3Biotech flourishes in 2005 while Big Pharma is on the decline 4Biotech flourishes in 2005 while Big Pharma is on the decline 5Biotech flourishes in 2005 while Big Pharma is on the decline 6Biotech flourishes in 2005 while Big Pharma is on the decline 7Biotech flourishes in 2005 while Big Pharma is on the decline 8
(Date:9/5/2008)...he National Science Foundation has awarded Iowa St...ar, $18.5 million grant to establish the NSF Engin...based at Iowa State. , The award is part of the ...ineering Research Centers (ERC) Program. The third...ned to create university and industry partnerships...
(Date:9/5/2008)...studies of aging typically utilize small, short-li...nditions constant temperature and humidity, no pa...dly enough, very little is known about aging in su...onments. Could it be that these laboratory "guinea...xury than do their wild cousins?, Nori Kawasaki, ...
(Date:9/5/2008)...holocate may have evolved more than once, accordin...niversity of London scientists. , Species of bat...ogether in the evolutionary tree of life - some ar...the fruit bats. This has raised the question of wh...nce, or whether the fruit bats somehow lost their ...
(Date:9/4/2008)...mber 2008 Even scientists define ,a gene, in diff...e media also have various ways of framing the conc...in the October 2008 issue of EMBO reports . , Th... of 300 articles in British and Norwegian newspape...the UK; and Aftenposten, Dagbladet, and VG from No...
Breaking Biology News(10 mins):Iowa State wins $18.5M grant to create NSF Center for Biorenewable Chemicals 2Iowa State wins $18.5M grant to create NSF Center for Biorenewable Chemicals 3Iowa State wins $18.5M grant to create NSF Center for Biorenewable Chemicals 4Old before their time? Aging in flies under natural vs. laboratory conditions 2Molecular evolution is echoed in bat ears 2What is a gene? 2Outsmart the Summer Sun at Any Age 16614 1Outsmart the Summer Sun at Any Age 16614 2Doctor Patient Talks Affect Use of Breast Reconstruction Surgery 16611 1Doctor Patient Talks Affect Use of Breast Reconstruction Surgery 16611 2Lung transplants in cystic fibrosis patients with life threatening bacteria sparks debate at ISHLT 16608 1Lung transplants in cystic fibrosis patients with life threatening bacteria sparks debate at ISHLT 16608 2UMDF Statement on the Connection Between Mitochondrial Disease and Autism 16606 1UMDF Statement on the Connection Between Mitochondrial Disease and Autism 16606 2
...rom the University of California-Davis recently de...ransfer among bacteria in the environment. Researc... models by taking into account characteristics of ...acteria hangouts. This model will help scientists ...ts. , The swapping of genetic material between bac...
...rm,s length won,t protect you from catching an inf...nsland University of Technology which reveals airb...Lidia Morawska, director of QUT,s International La...y dispelled the myth that viruses emitted from hum...r Morawska and a team of QUT scientists have been ...
...ronic herpes virus infections can better resist th...t causes one kind of food poisoning, researchers r...ngton University School of Medicine in St. Louis a... immune system triggered by the long-term presence...al infections, the virus is present for the lifeti...
...at prevents HIV infection remains an important goa...IV vaccine candidates may not work in this way, sa...and Infectious Diseases (NIAID), part of the Natio...successful preventive HIV vaccines, if administere... the body, thereby delaying the progression to AID...
Other Biology News:Researchers develop way to calculate speed of bacterial sex 2Spreading viruses as we breathe 2Herpes infection may be symbiotic, help beat back some bacteria 2Herpes infection may be symbiotic, help beat back some bacteria 3Herpes infection may be symbiotic, help beat back some bacteria 4The quest for an effective HIV vaccine presents new possibilities, challenges 2The quest for an effective HIV vaccine presents new possibilities, challenges 3The quest for an effective HIV vaccine presents new possibilities, challenges 4
Ideally suited for resolving DNA and RNA 10-1000 bases especially PCR products ranging from 100-1000 bp. Gelling temp. (4%) 27C Melting temperature 65C. EEO: 0.10 Rnase/Dnase: none detected
Pharmalyte, narrow range pH 4.2-4.9, 25 ml. Category: Electrophoresis Systems & Standards & Reagents, Electrophoresis Standards and Reagents, Immobiline for IEF and Carrier Ampholytes.
Low melting point. Ideally suited for in gel enzymatic reactions. Gelling temp. 24-28C Melting temp. 65C. EEO 0.12 Resolution 0.5-20 kb; Rnase/Dnase: none detected.
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3
Biology Products: